hydrazine has been researched along with Coronary Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (72.22) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katayama, Y; Komada, T; Kusagawa, H; Shomura, S | 1 |
| FRIEDGOOD, CE | 1 |
| LEVY, H; PADER, E | 1 |
| Castell, MF; Hachenberger, J; Haller, C; Vahl, CF; Witte, K | 1 |
| Brooks, LA; Dellsperger, KC; Eller, BT | 1 |
| Agapova, EN | 1 |
| Anderson, HV; Benedict, CR; Buja, LM; Campbell, WB; Cui, K; Maffrand, JP; McNatt, J; Ober, JC; Rosolowsky, M; Yao, SK | 1 |
| Anderson, HV; Buja, LM; De Clerck, F; Golino, P; NcNatt, JM; Rosolowsky, M; Willerson, JT; Yao, SK | 1 |
| Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; O'Brien, RA; Willerson, JT; Yao, SK | 1 |
| Ashton, JH; Buja, LM; Golino, P; McNatt, JM; Willerson, JT | 1 |
| Allison, P; Ashton, J; Buja, LM; Eidt, JF; Golino, P; McNatt, J; Noble, S; Willerson, JT | 2 |
| Grover, GJ; Parham, CS | 1 |
| Brezinski, ME; Hock, CE; Lefer, AM | 1 |
| Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; Willerson, JT | 1 |
| Ashton, JH; Buja, LM; Golino, P; Kulkarni, P; Taylor, A; Willerson, JT | 1 |
| Kislaia, TV; Popova, NK; Shmerling, MD | 1 |
| Agapova, EN; Krutovskaia, OV; Mikhaĭlovskaia, IG | 1 |
18 other study(ies) available for hydrazine and Coronary Disease
| Article | Year |
|---|---|
[Effectiveness of perioperative administration of eltrombopag in a patient with idiopathic thrombocytopenic purpura undergoing cardiovascular surgery].
Topics: Aged; Aortic Aneurysm; Aortic Dissection; Benzoates; Coronary Artery Bypass; Coronary Disease; Humans; Hydrazines; Male; Perioperative Period; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Thrombopoietin | 2014 |
Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome.
Topics: Angina Pectoris; Coronary Artery Disease; Coronary Disease; Hydrazines; Monoamine Oxidase Inhibitors; Oxidoreductases | 1960 |
The effect of phenylethylhydrazine dihydrogen sulfate (nardil) on total serum cholesterol.
Topics: Cardiotonic Agents; Cholesterol; Coronary Disease; Hydrazines; Oxidoreductases; Phenelzine; Sulfates; Sulfuric Acids | 1960 |
Nitric oxide-sensitive soluble guanylyl cyclase activity is preserved in internal mammary artery of type 2 diabetic patients.
Topics: Aged; Coronary Disease; Cyclic GMP; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Guanylate Cyclase; Humans; Hydrazines; Male; Mammary Arteries; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Ventricular Dysfunction, Left | 2004 |
Thromboxane contributes to submaximal coronary dilation during myocardial ischemia.
Topics: Animals; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Microcirculation; Muscle Tonus; Thromboxanes; Vasodilation; Video Recording | 1995 |
[Use of vetrazine in ischemic heart disease].
Topics: Aged; Coronary Disease; Drug Evaluation; Female; Humans; Hydrazines; Male; Middle Aged | 1975 |
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Topics: Adenosine Diphosphate; Animals; Apyrase; Bridged Bicyclo Compounds, Heterocyclic; Clopidogrel; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Thromboxane A2; Ticlopidine | 1992 |
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Epoprostenol; Ergolines; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase | 1990 |
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Ergolines; Fatty Acids, Unsaturated; Hydrazines; Myocardial Reperfusion; Platelet Aggregation; Recombinant Proteins; Recurrence; Serotonin; Serotonin Antagonists; Thromboxane A2; Time Factors; Tissue Plasminogen Activator | 1989 |
Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
Topics: Animals; Blood Flow Velocity; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Ergolines; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Yohimbine | 1989 |
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
Topics: Animals; Antithrombin III; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hemodynamics; Heparin; Hydrazines; Ketanserin; Male; Peptide Hydrolases; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin | 1989 |
Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Myocardium; Oxygen Consumption; Thromboxane A2; Time Factors | 1989 |
Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Coronary Vessels; Creatine Kinase; Fatty Acids, Unsaturated; Heart Rate; Hemodynamics; Hydrazines; Male; Myocardium; Oxygen Consumption; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane | 1986 |
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Fatty Acids, Unsaturated; Hydrazines; Ketanserin; Platelet Aggregation; Recombinant Proteins; Recurrence; Serotonin; Thromboxane A2; Tissue Plasminogen Activator | 1988 |
Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
Topics: Animals; Antithrombins; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Fatty Acids, Unsaturated; Female; Heparin; Hydrazines; Ketanserin; Male; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin; Thromboxane A2 | 1988 |
Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Coronary Vessels; Dogs; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Platelet Aggregation; Receptors, Serotonin; Serotonin Antagonists; Thromboxane A2 | 1988 |
[Changes in the arterial bed of the myocardium following administration of hydrazine derivatives].
Topics: Angiocardiography; Animals; Anti-Arrhythmia Agents; Capillaries; Coronary Disease; Coronary Vessels; Dogs; Hydrazines; Iproniazid; Isoniazid | 1966 |
[Blood coagulation characteristics and fibrinolytic activity in patients with coronary arteriosclerosis during a course of treatment with vetrazine].
Topics: Blood Coagulation; Blood Coagulation Tests; Coronary Disease; Fibrinolysis; Humans; Hydrazines; Monoamine Oxidase Inhibitors | 1968 |